Direct effect of protein kinase C inhibitors on cardiovascular ion channels
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Protein kinase C (PKC) is a central enzyme that modulates numerous biological functions. For this reason, specific PKC inhibitors/activators are required to study PKC-related signaling mechanisms. To date, although many PKC inhibitors have been developed, they are limited by poor selectivity and nonspecificity. In this review, we focus on the nonspecific actions of PKC inhibitors on cardiovascular ion channels in addition to their PKC-inhibiting functions. The aim of this paper is to urge caution when using PKC inhibitors to block PKC function. This information may help to better understand PKC-related physiological/biochemical studies. [BMB reports 2011; 44(9): 559-565]
Abstract
Protein kinase C (PKC) is a central enzyme that modulates numerous biological functions. For this reason, specific PKC inhibitors/activators are required to study PKC-related signaling mechanisms. To date, although many PKC inhibitors have been developed, they are limited by poor selectivity and nonspecificity. In this review, we focus on the nonspecific actions of PKC inhibitors on cardiovascular ion channels in addition to their PKC-inhibiting functions. The aim of this paper is to urge caution when using PKC inhibitors to block PKC function. This information may help to better understand PKC-related physiological/biochemical studies. [BMB reports 2011; 44(9): 559-565]
참고문헌 (55)
- Divecha, N, "Phospholipid signaling", Cell, 80, pp.269~278 (1995)
- Nishizuka, Y, "Protein kinase C and lipid signaling for sustained cellular responses", FASEB. J, 9, pp.484~496 (1995)
- Tamaoki, T, "Staurosporine, a potent inhibitor of phospholipid", Ca2+ dependent protein kinase, 1986, pp.135, 397~402
- Toullec, D, "The bisindolylmaleimide GF 109203X is potent and selective inhibitor of protein kinase C", J. Biol. Chem, 266, pp.15771~15781 (1991)
- Roffey, J, "Protein kinase C intervention: the state of play", Curr. Opin. Cell Biol, 21, pp.268~279 (2009)
- Furusaki, A, "X-Ray crystal structure of staurosporine: a new alkaloid from a Streptomyces strain", J. Chem. Soc. Chem. Commun, 18, pp.800~801 (1978)
- Meggio, F, "Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2", Eur. J. Biochem, 234, pp.317~322 (1995)
- oxadiazacyclohexadecene-1,3 (2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta, "J. Med. Chem", 1996, 2664~2671
- Green, L. J, "Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor", Clin. Cancer Res, 12, pp.3408~3415 (2006)
- Kobayashi, E, "Calphostins (UCN- 1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physic-chemical properties and biological activities", J. Antibiot, 42, pp.1470~1474 (1989)
- Kazanietz, M. G, "Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligandbinding interactions, lipid cofactor requirements, and inhibitor sensitivity", J. Biol. Chem, 270, pp.10777~10783 (1995)
- Bruns, R. F, "Inhibition of protein kinase C by calphostin C is light-dependent", Biochem. Biophys. Res. Commun, 176, pp.288~293 (1991)
- Churchill, E. N, "Rationally designed peptide regulators of protein kinase C", Trends Endocrinol. Metab, 20, pp.25~33 (2009)
- Herbert, J. M, "chelerythrine is a potent and specific inhibitor of protein kinase C", Biochem. Biophys. Res. Commun, 172, pp.993~999 (1990)
- Eckly-Michel, A. E, "Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases", Eur. J. Pharmacol, 324, pp.85~88 (1997)
- Zamora, M. A, "BQ123, and ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human artery smooth muscle cells", Am. J. Respir. Cell Mol. Biol, 9, pp.429~433 (1993)
- Newton, A. C, "Regulation of protein kinase C", Curr. Opin. Cell Biol, 9, pp.161~167 (1997)
- Shimoda, L. A, "Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1", Am. J. Physiol, 274, pp.842~853 (1998)
- Li, P. F, "Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells", Circulation, 100, pp.967~973 (1999)
- Inoue, Y, "Endothelin augments unitary calcium channel currents on the smooth muscle cell membrane of guinea-pig portal vein", J. Physiol, 423, pp.171~191 (1990)
- Van Renterghem, C, "Endothelin and vasopressin activate low conductance chloride channels in aortic smooth muscle cells", Pflugers. Arch, 425, pp.156~163 (1993)
- Nakajima, T, "Endothelin-1 and vasopressin activate Ca2+-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptor-mediated Ca2+ influx", J. Mol. Cell Cardiol, 28, pp.707~722 (1996)
- Park, W. S, "Endothelin-1 acts via protein kinase C to block KATP channels in rabbit coronary and pulmonary arterial smooth muscle cells", J. Cardiovasc. Pharmacol, 45, pp.99~108 (2005)
- Park, W. S, "Endothelin-1 inhibits inward rectifier K+ channels in rabbit coronary arterial smooth muscle cells through protein kinase C", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 46, pp.681~689 (2005), LIPPINCOTT WILLIAMS & WILKINS
- Park, W. S, "Staurosporine inhibits voltage-dependent K+ current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 45, pp.260~269 (2005), LIPPINCOTT WILLIAMS & WILKINS
- French, R. J, "Blockage of squid axon potassium conductance by internal tetra-N-alkylammonium ions of various sizes", Biophys. J, 34, pp.271~291 (1981)
- Hoshi, T, "Biophysical and molecular mechanisms of Shaker potassium channel inactivation", Science, 250, pp.533~538 (1990)
- Heginbotham, L, "The aromatic binding site for tetraethylammonium ion on potassium channels", Neuron, 8, pp.483~491 (1992)
- Snyders, D. J, "Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel", Circ. Res, 77, pp.575~583 (1995)
- del Camino, D, "Camino, D., Holmgren, M., Liu, Y. and Yellen, G. (2000) Blocker protection in the pore of a voltage-gated K+ channel and its structural implications", Nature, 403, pp.321~325 (2000)
- Kageyama, M, "Is staurosporine a specific inhibitor of protein kinase C in intact porcine coronary arteries", J. Pharmacol. Exp. Ther, 259, pp.1019~1026 (1991)
- Ko, J. H, "The protein kinase inhibitor, staurosporine, inhibits L-type Ca2+ current in rabbit atrial myocytes", Biochem. Biophys. Res. Commun, 329, pp.531~537 (2005)
- Ko, J. H, "Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes", EUROPEAN JOURNAL OF PHARMACOLOGY, 534, pp.48~54 (2006), ELSEVIER SCIENCE BV
- Narahashi, T, "Neuronal ion channels as the target sites of insecticides", Pharmacol. Toxico, 79, pp.1~14 (1996)
- Catterall, W. A, "From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels", Neuron, 26, pp.13~25 (2000)
- Goldin, A. L, "Resurgence of sodium channel research", Annu. Rev. Physiol, 63, pp.871~894 (2001)
- Lo, C. F, "Protein kinase-independent inhibition of muscarinic K+ channels by staurosporine", Am. J. Physiol, 266, pp.1128~1132 (1994)
- 최진성, "Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells", NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 359, pp.256~261 (1999), SPRINGER
- Valenzuela, C, "Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels", Circulation, 94, pp.562~570 (1996)
- Park, W. S, "The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells", LIFE SCIENCES, 77, pp.512~527 (2005), PERGAMON-ELSEVIER SCIENCE LTD
- Kim, A, "Direct block by bisindolylmaleimide of the voltage-dependent K+ currents of rat mesenteric arterial smooth muscle", Eur. J. Pharmacol, 483, pp.117~126 (2004)
- Voutilainen-Mylylä, S, "Chelerythrine and bisindolylmaleimide I prolong cardiac action potentials by protein kinase C-independent mechanism", Eur. J. Pharmacol, 466, pp.41~51 (2003)
- Cho, H, "Inhibition of acetylcholine-activated K+ current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice", Eur. J. Pharmacol, 424, pp.173~178 (2001)
- 박원선, "A Carbohydrate Fraction, AIP1, from Artemisia Iwayomogi Reduces the Action Potential Duration by Activation of Rapidly Activating Delayed Rectifier K+ Channels in Rabbit Ventricular Myocytes", The Korean Journal of Physiology & Pharmacology, 14(3), pp.119~125 (2010), 대한약리학회
- Thomas, D, "Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X)", Cardiovasc. Res, 64, pp.467~476 (2004)
- Ficker, E, "Mechanisms of arsenic-induced prolongation of cardiac repolarization", Mol. Pharmacol, 66, pp.33~44 (2004)
- 최진성, "Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 293, pp.634~640 (2000), AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
- Lingameneni, R, "Inhibition of voltage-dependent sodium channels by Ro 31-8220, a ‘specific’ protein kinase C inhibitor", FEBS Lett, 473, pp.265~268 (2000)
- Shi, L, "Inhibitory effect of the kinase inhibitor chelerythrine on acetylcholine-induced current in PC12 cells", Arch. Biochem. Biophys, 368, pp.40~44 (1999)
- Murphy, C. T, "Selective inhibition of protein kinase C. Effect on platelet-activating- factor-induced platelet functional responses", Biochem. J, 283, pp.159~164 (1992)
- Keenan, C, "Isoform specificity of activators and inhibitors of protein kinase C gamma and delta", FEBS Lett, 415, pp.101~108 (1997)
- Zakharov, S. I, "Activation of the BK (SLO1) potassium channel by mallotoxin", J. Biol. Chem, 280, pp.30882~30887 (2005)
- Wu, S. N, "Potent stimulation of large-conductance Ca2+-activated K+ channels by rottlerin, an inhibitor of protein kinase C-delta, in pituitary tumor (GH3) cells and in cortical neuronal (HCN-1A) cells", J. Cell Physiol, 210, pp.656~666 (2007)
- Butler, A, "mSlo, a complex mouse gene encoding “maxi” calcium-activated potassium channels", Science, 261, pp.221~224 (1993)
- Ghatta, S, "Large-conductance, calcium-activated potassium channels: Structural and functional implications", Pharmacol. Ther, 110, pp.103~116 (2006)
